GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

BIOAB

319.6

+1.91%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

BIOAB

319.6

+1.91%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

BIOAB

319.6

+1.91%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

BIOAB

319.6

+1.91%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

BIOAB

319.6

+1.91%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

Inicio・Lista de Acciones・Vivesto AB

Vivesto AB

Cerrado

0.22

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

0.22

Máximo

0.22

Métricas clave
By Trading Economics
Ingresos	2.3M -7.2M
BPA	-0.013
Empleados	4

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-8.8M 69M
Apertura anterior	0.22
Cierre anterior	0.22

Vivesto AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 dic 2025, 17:29 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dic 2025, 16:47 UTC

Principales Movimientos del Mercado

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dic 2025, 16:10 UTC

Adquisiciones, fusiones, absorciones

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

20 dic 2025, 19:00 UTC

Ganancias

Consumer Confidence, Economic Activity Data, and a Short Trading Week for Christmas -- Barrons.com

19 dic 2025, 22:33 UTC

Ganancias

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dic 2025, 22:19 UTC

Ganancias

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dic 2025, 21:48 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 21:44 UTC

Ganancias

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 21:38 UTC

Ganancias

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dic 2025, 21:00 UTC

Charlas de Mercado

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dic 2025, 20:23 UTC

Charlas de Mercado

Oil Futures End Down Week on Up Note -- Market Talk

19 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dic 2025, 18:38 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dic 2025, 18:00 UTC

Charlas de Mercado

Ganancias

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dic 2025, 17:41 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dic 2025, 17:24 UTC

Charlas de Mercado

Ganancias

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

19 dic 2025, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

19 dic 2025, 16:29 UTC

Ganancias

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dic 2025, 16:20 UTC

Adquisiciones, fusiones, absorciones

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dic 2025, 16:19 UTC

Adquisiciones, fusiones, absorciones

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dic 2025, 16:18 UTC

Adquisiciones, fusiones, absorciones

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dic 2025, 16:16 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 dic 2025, 16:16 UTC

Charlas de Mercado

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dic 2025, 16:05 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 16:04 UTC

Adquisiciones, fusiones, absorciones

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dic 2025, 15:37 UTC

Charlas de Mercado

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

19 dic 2025, 15:21 UTC

Charlas de Mercado

West-Coast Liquor Store Strike Weighed on Canada Retail Data -- Market Talk

19 dic 2025, 15:09 UTC

Charlas de Mercado

Gold Flat But Set for Weekly Gains -- Market Talk

19 dic 2025, 15:09 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Vivesto AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.